Literature DB >> 10845978

Costing in economic evaluation.

J Raftery1.   

Abstract

Mesh：

Year:  2000        PMID： 10845978      PMCID： PMC1127376          DOI： 10.1136/bmj.320.7249.1597

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Benchmarking costs in health services.

Authors:  J Raftery
Journal:  J Health Serv Res Policy       Date:  1999-04

2.  Perspectives in economic evaluation.

Authors:  S Byford; J Raftery
Journal:  BMJ       Date:  1998-05-16
  2 in total
  17 in total

Review 1.  How are the costs of drug-related morbidity measured?: a systematic literature review.

Authors:  Hanna Gyllensten; Anna K Jönsson; Clas Rehnberg; Anders Carlsten
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

Review 2.  A Review of Health Economic Studies Comparing Traditional and Massively Parallel Sequencing Diagnostic Pathways for Suspected Genetic Disorders.

Authors:  Patrick Fahr; James Buchanan; Sarah Wordsworth
Journal:  Pharmacoeconomics       Date:  2020-02       Impact factor: 4.981

3.  Cost of illness of cystic fibrosis in Germany: results from a large cystic fibrosis centre.

Authors:  Mareike Heimeshoff; Helge Hollmeyer; Jonas Schreyögg; Oliver Tiemann; Doris Staab
Journal:  Pharmacoeconomics       Date:  2012-09-01       Impact factor: 4.981

4.  Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study.

Authors:  Andrea L Jorgensen; Sameh Al-Zubiedi; Jieying Eunice Zhang; Andrew Keniry; Anita Hanson; Dyfrig A Hughes; Diane van Eker; Lisa Stevens; Karen Hawkins; Cheng H Toh; Farhad Kamali; Ann K Daly; David Fitzmaurice; Alison Coffey; Paula R Williamson; Brian Kevin Park; Panos Deloukas; Munir Pirmohamed
Journal:  Pharmacogenet Genomics       Date:  2009-10       Impact factor: 2.089

5.  Staff costs of hospital-based outpatient care of patients with cystic fibrosis.

Authors:  Helge Hollmeyer; Jonas Schreyögg; Ulrich Wahn; Doris Staab
Journal:  Health Econ Rev       Date:  2011-08-03

6.  Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities.

Authors:  Germaine Wong; Kirsten Howard; Jeremy R Chapman; Steven Chadban; Nicholas Cross; Allison Tong; Angela C Webster; Jonathan C Craig
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

7.  Protocol for north of England and Scotland study of tonsillectomy and adeno-tonsillectomy in children (NESSTAC). A pragmatic randomised controlled trial comparing surgical intervention with conventional medical treatment in children with recurrent sore throats.

Authors:  John Bond; Janet Wilson; Martin Eccles; Alessandra Vanoli; Nick Steen; Ray Clarke; Andrew Zarod; Catherine Lock; Katie Brittain; Chris Speed; Nikki Rousseau
Journal:  BMC Ear Nose Throat Disord       Date:  2006-08-09

8.  A randomised controlled trial of a patient based Diabetes Recall and Management System: the DREAM trial: a study protocol [ISRCTN32042030].

Authors:  Martin Eccles; Gillian Hawthorne; Paula Whitty; Nick Steen; Alessandra Vanoli; Jeremy Grimshaw; Linda Wood
Journal:  BMC Health Serv Res       Date:  2002-03-21       Impact factor: 2.655

9.  Costs and effects of a state-wide health promotion program in primary schools in Germany - the Baden-Württemberg Study: A cluster-randomized, controlled trial.

Authors:  Dorothea Kesztyüs; Romy Lauer; Tibor Kesztyüs; Reinhold Kilian; Jürgen M Steinacker
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

10.  A Checklist for the Conduct, Reporting, and Appraisal of Microcosting Studies in Health Care: Protocol Development.

Authors:  Jennifer Prah Ruger; Marian Reiff
Journal:  JMIR Res Protoc       Date:  2016-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.